About Rinascera Therapeutics
Rinascera Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2025 in Delaware. It has reported $2,500,000 raised in one offering on Form D since October 2025. Its chief executive is Nichola Eliovits.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 12, 2025 | Oct 8, 2025 | $2,500,000fully sold | 3 | $833K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Rinascera Therapeutics's Form D filed Oct 8, 2025.
NE
Nichola Eliovits
Chief Executive Officer and director
Also an executive officer and director at DermBiont and a director at MaverickX and Phoenix Tailings.
MD
DY
KB